S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Start Premium Trial||Register For Free|
|P||F||Fund Financial Data (13,000+ funds)|
|P||F||Stock Financial Data (7,000+ stocks)|
|P||F||Stock and Fund Screeners (basic)|
|P||F||Investing Articles and Market Commentary|
|P||F||Articles Archive (>30 days)|
|P||F||Discuss (dozens of stock, fund, bond, and general bulletin boards)|
|P||F||Portfolio Manager (basic)|
|P||F||Morningstar Investment Classroom|
|P||F||Access Your Portfolio Anytime, Anywhere via Your Mobile Device|
|P||Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)|
|P||Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)|
|P||Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)|
|P||Portfolio Monitor (monthly and on-demand personalized portfolio statements)|
|P||Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters|
|P||Discounts on Morningstar newsletters, books, seminars, and more|
Join Morningstar today. It's Free.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.
|Galena Biopharma Reports Third Quarter 2013 Results (2013/11/6)|
|Galena Biopharma Initiates RELIEF Patient Registry for Abstral(R) (fentanyl) Sublingual Tablets (2013/9/3)|
|Galena Biopharma Announces Initial Results From the Folate Binding Protein Vaccine Phase 1 Trial at the Society for Immunotherapy of Cancer Conference (2013/11/11)|
|Galena Biopharma Reports Second Quarter 2013 Financial Results ()|
|Galena Biopharma Announces Oral Presentation at the American College of Surgeons Clinical Congress 2013 (2013/10/7)|
|Galena Biopharma Announces Closing of Over-Allotment Option, Increasing Total Gross Proceeds to $40 Million (2013/9/23)|
|Galena Biopharma Launches Abstral(R) (fentanyl) Sublingual Tablets for the Treatment of Breakthrough Cancer Pain (2013/10/3)|
|Galena Biopharma Expands NeuVax(TM) Intellectual Property With European Allowance (2013/8/21)|
|Galena Biopharma Announces Closing of Public Offering of Common Stock and Warrants (2013/9/18)|
|Galena Biopharma Announces Pricing of Public Offering of Common Stock and Warrants (2013/9/13)|
Click above to view more mutual fund data and stats for gale - Galena Biopharma Inc.